Pasar al contenido principal

MODULATION OF THE ADIPOSE TISSUE AND AGRP NEURONS’ LIPID METABOLISM TO COUNTERACT OBESITY AND DIABETES

PID2020-114953RB-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Interleukin-16 is increased in obesity and alters adipogenesis and inflammation in vitro

  • Reyes-Farias, Marjorie|||0000-0001-9179-7251
  • Fernández-García, Pablo|||0000-0001-8018-5954
  • Corrales, Patricia|||0000-0002-9817-8389
  • González, Lorena
  • Soria-Gondek, Andrea|||0000-0002-7210-0073
  • Martínez, Ester
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Tarascó, Jordi
  • Moreno Santabarbara, Pablo|||0000-0002-6652-120X
  • Sumoy, Lauro|||0000-0003-0005-4618
  • Medina-Gómez, Gema|||0000-0001-8169-681X
  • Sánchez-Infantes, David|||0000-0001-6086-7501
  • Herrero, Laura|||0000-0003-4244-4673
Introduction: Obesity is a chronic condition associated with low-grade inflammation mainly due to immune cell infiltration of white adipose tissue (WAT). WAT is distributed into two main depots: subcutaneous WAT (sWAT) and visceral WAT (vWAT), each with different biochemical features and metabolic roles. Proinflammatory cytokines including interleukin (IL)-16 are secreted by both adipocytes and infiltrated immune cells to upregulate inflammation. IL-16 has been widely studied in the peripheral proinflammatory immune response; however, little is known about its role in adipocytes in the context of obesity. Aim & Methods: We aimed to study the levels of IL-16 in WAT derived from sWAT and vWAT depots of humans with obesity and the role of this cytokine in palmitate-exposed 3T3-L1 adipocytes. Results: The results demonstrated that IL-16 expression was higher in vWAT compared with sWAT in individuals with obesity. In addition, IL-16 serum levels were higher in patients with obesity compared with normal-weight individuals, increased at 6 months after bariatric surgery, and at 12 months after surgery decreased to levels similar to before the intervention. Our in vitro models showed that IL-16 could modulate markers of adipogenesis (Pref1), lipid metabolism (Plin1, Cd36, and Glut4), fibrosis (Hif1a, Col4a, Col6a, and Vegf), and inflammatory signaling (IL6) during adipogenesis and in mature adipocytes. In addition, lipid accumulation and glycerol release assays suggested lipolysis alteration. Discussion: Our results suggest a potential role of IL-16 in adipogenesis, lipid and glucose homeostasis, fibrosis, and inflammation in an obesity context.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

CPT1A in AgRP neurons is required for sex-dependent regulation of feeding and thirst

  • Zagmutt, Sebastián
  • Martin, Beatriz
  • Esteve-Codina, Anna
  • Serra, Dolors
Background: Fatty acid metabolism in the hypothalamus has an important role in food intake, but its specific role in AgRP neurons is poorly understood. Here, we examined whether carnitinea palmitoyltransferase 1A (CPT1A), a key enzyme in mitochondrial fatty acid oxidation, affects energy balance. Methods: To obtain Cpt1aKO mice and their control littermates, Cpt1a(flox/flox) mice were crossed with tamoxifen-inducible AgRPCreERT2 mice. Food intake and body weight were analyzed weekly in both males and females. At 12 weeks of age, metabolic flexibility was determined by ghrelin-induced food intake and fasting-refeeding satiety tests. Energy expenditure was analyzed by calorimetric system and thermogenic activity of brown adipose tissue. To study fluid balance the analysis of urine and water intake volumes; osmolality of urine and plasma; as well as serum levels of angiotensin and components of RAAS (renin-angiotensin-aldosterone system) were measured. At the central level, changes in AgRP neurons were determined by: (1) analyzing specific AgRP gene expression in RiboTag-Cpt1aKO mice obtained by crossing Cpt1aKO mice with RiboTag mice; (2) measuring presynaptic terminal formation in the AgRP neurons with the injection of the AAV1-EF1a-DIO-synaptophysin-GFP in the arcuate nucleus of the hypothalamus; (3) analyzing AgRP neuronal viability and spine formations by the injection AAV9-EF1a-DIO-mCherry in the arcuate nucleus of the hypothalamus; (4) analyzing in situ the specific AgRP mitochondria in the ZsGreen-Cpt1aKO obtained by breeding ZsGreen mice with Cpt1aKO mice. Two-way ANOVA analyses were performed to determine the contributions of the effect of lack of CPT1A in AgRP neurons in the sex. Results: Changes in food intake were just seen in male Cpt1aKO mice while only female Cpt1aKO mice increased energy expenditure. The lack of Cpt1a in the AgRP neurons enhanced brown adipose tissue activity, mainly in females, and induced a substantial reduction in fat deposits and body weight. Strikingly, both male and female Cpt1aKO mice showed polydipsia and polyuria, with more reduced serum vasopressin levels in females and without osmolality alterations, indicating a direct involvement of Cpt1a in AgRP neurons in fluid balance. AgRP neurons from Cpt1aKO mice showed a sex-dependent gene expression pattern, reduced mitochondria and decreased presynaptic innervation to the paraventricular nucleus, without neuronal viability alterations. Conclusions: Our results highlight that fatty acid metabolism and CPT1A in AgRP neurons show marked sex differences and play a relevant role in the neuronal processes necessary for the maintenance of whole-body fluid and energy balance., This study was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) (SAF2017-83813-C3-1-R to DS and LH, cofunded by the European Regional Development Fund [ERDF] and PID2020-114953RB-C21 to LH and DS, RTI2018-094727-B-100 to JMG; SAF2017-88108-R to AQ; AEI (PID2020-114977RB-I00) to AQ, ERC-2014-StG-638106 to AQ, MICINN RYC2019-028501-I to ES; MICIU RTI2018-101838-J-I00 to ES; a doctoral fellowship to SZ, and a Juan de la Cierva-Incorporación Research Fellowship [IJCI-2016-28313] to PM and DS), the Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) (CB06/03/0001 to DS and LH), the Government of Catalonia (2014SGR465 to DS), and La Marató de TV3 (201627-30 to DS). AO is supported by a Miguel Servet contract (CP19/00083) from Instituto de Salud Carlos III co-financed by European Regional Development Fund [ERDF]. AE is funded by ISCIII /MINECO (PT17/0009/0019) and co-funded by FEDER.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Role of long non-coding RNAs in adipose tissue metabolism and associated pathologies

  • Corral, Ana
  • Alcalá, Martin
  • Durán Ruiz, María del Carmen
  • Arroba Espinosa, Ana Isabel
  • Ponce González, Jesús Gustavo
  • Todorčević, Marijana
  • Serra, Dolors
  • Calderón Domínguez, María
  • Herrero, Laura
The incidence of obesity and its related disorders has increased dramatically in recent years and has become a pandemic. Adipose tissue is a crucial regulator of these diseases due to its endocrine capacity. Thus, understanding adipose tissue metabolism is essential to finding new effective therapeutic approaches. The "omic" revolution has identified new concepts about the complexity of the signaling pathways involved in the pathophysiology of adipose tissue-associated disorders. Specifically, advances in transcriptomics have allowed its application in clinical practice and primary or secondary prevention. Long non-coding RNAs (lncRNAs) have emerged as critical regulators of adipose tissue since they can modulate gene expression at the epigenetic, transcriptional, and post-transcriptional levels. They interact with DNA, RNA, protein complexes, other noncoding RNAs, and microRNAs to regulate a wide range of physiological and pathological processes. Here, we review the emerging field of lncRNAs, including how they regulate adipose tissue biology, and discuss circulating lncRNAs, which may represent a turning point in the diagnosis and treatment of adipose tissue-associated disorders. We also highlight potential biomarkers of obesity and diabetes that could be considered as therapeutic targets., This study was supported by the Spanish Ministry of Science and Innovation (MCIN) (PID2020-114953RB-C21 to LH and DS, co-funded by the European Regional Development Fund [ERDF], PID2020-114343GA-100 to MA, and PID2019-110063RA-I00 to JP and MC), the Biomedical Research Centre in Pathophysiology of Obesity and Nutrition (CIBEROBN) (Grant CB06/03/0001 to LH), and the Merck Health Foundation (to LH). AC is a recipient of the Formación de Personal Investigador (FPI) doctoral fellowship from the MCIN.‬‬‬‬‬‬ We thank MCarmen Soler-Vázquez for her expert assistance in the preparation of Fig. 1 .
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CPT1A in AgRP neurons is required for sex-dependent regulation of feeding and thirst

  • Zagmutt, Sebastián
  • Mera, Paula
  • González-García, Ismael
  • Ibeas, Kevin
  • Romero, María del Mar
  • Obri, Arnaud
  • Martin, Beatriz
  • Esteve-Codina, Anna
  • Soler-Vázquez, M. Carmen
  • Bastias-Pérez, Marianela
  • Cañes, Laia
  • Augé, Elisabeth
  • Pelegri, Carme
  • Vilaplana, Jordi
  • Ariza, Xavier
  • García, Jordi
  • Martínez-González, José
  • Casals, Núria
  • López, Miguel
  • Palmiter, Richard
  • Sanz, Elisenda
  • Quintana, Albert
  • Herrero, Laura
  • Serra, Dolors
Background: Fatty acid metabolism in the hypothalamus has an important role in food intake, but its specific role in AgRP neurons is poorly understood. Here, we examined whether carnitinea palmitoyltransferase 1A (CPT1A), a key enzyme in mitochondrial fatty acid oxidation, affects energy balance. Methods: To obtain Cpt1aKO mice and their control littermates, Cpt1a mice were crossed with tamoxifen-inducible AgRP mice. Food intake and body weight were analyzed weekly in both males and females. At 12 weeks of age, metabolic flexibility was determined by ghrelin-induced food intake and fasting–refeeding satiety tests. Energy expenditure was analyzed by calorimetric system and thermogenic activity of brown adipose tissue. To study fluid balance the analysis of urine and water intake volumes; osmolality of urine and plasma; as well as serum levels of angiotensin and components of RAAS (renin–angiotensin–aldosterone system) were measured. At the central level, changes in AgRP neurons were determined by: (1) analyzing specific AgRP gene expression in RiboTag–Cpt1aKO mice obtained by crossing Cpt1aKO mice with RiboTag mice; (2) measuring presynaptic terminal formation in the AgRP neurons with the injection of the AAV1-EF1a-DIO-synaptophysin-GFP in the arcuate nucleus of the hypothalamus; (3) analyzing AgRP neuronal viability and spine formations by the injection AAV9-EF1a-DIO-mCherry in the arcuate nucleus of the hypothalamus; (4) analyzing in situ the specific AgRP mitochondria in the ZsGreen-Cpt1aKO obtained by breeding ZsGreen mice with Cpt1aKO mice. Two-way ANOVA analyses were performed to determine the contributions of the effect of lack of CPT1A in AgRP neurons in the sex. Results: Changes in food intake were just seen in male Cpt1aKO mice while only female Cpt1aKO mice increased energy expenditure. The lack of Cpt1a in the AgRP neurons enhanced brown adipose tissue activity, mainly in females, and induced a substantial reduction in fat deposits and body weight. Strikingly, both male and female Cpt1aKO mice showed polydipsia and polyuria, with more reduced serum vasopressin levels in females and without osmolality alterations, indicating a direct involvement of Cpt1a in AgRP neurons in fluid balance. AgRP neurons from Cpt1aKO mice showed a sex-dependent gene expression pattern, reduced mitochondria and decreased presynaptic innervation to the paraventricular nucleus, without neuronal viability alterations. Conclusions: Our results highlight that fatty acid metabolism and CPT1A in AgRP neurons show marked sex differences and play a relevant role in the neuronal processes necessary for the maintenance of whole-body fluid and energy balance., This study was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) (SAF2017-83813-C3-1-R to DS and LH, cofunded by the European Regional Development Fund [ERDF] and PID2020-114953RB-C21 to LH and DS, RTI2018-094727-B-100 to JMG; SAF2017-88108-R to AQ; AEI (PID2020-114977RB-I00) to AQ, ERC-2014-StG-638106 to AQ, MICINN RYC2019-028501-I to ES; MICIU RTI2018-101838-J-I00 to ES; a doctoral fellowship to SZ, and a Juan de la Cierva-Incorporación Research Fellowship [IJCI-2016-28313] to PM and DS), the Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) (CB06/03/0001 to DS and LH), the Government of Catalonia (2014SGR465 to DS), and La Marató de TV3 (201627-30 to DS). AO is supported by a Miguel Servet contract (CP19/00083) from Instituto de Salud Carlos III co-financed by European Regional Development Fund [ERDF]. AE is funded by ISCIII /MINECO (PT17/0009/0019) and co-funded by FEDER.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice

  • Soler-Vázquez, M. Carmen
  • Romero, María del Mar
  • Todorcevic, Marijana
  • Delgado, Katia
  • Calatayud, Carles
  • Benitez-Amaro, Aleyda
  • La Chica Lhoëst, Maria Teresa
  • Mera, Paula
  • Zagmutt, Sebastián
  • Bastias-Pérez, Marianela
  • Ibeas, Kevin
  • Casals, Núria
  • Escolà-Gil, Joan Carles
  • Llorente-Cortés, Vicenta
  • Consiglio, Antonella
  • Serra, Dolors
  • Herrero, Laura
Obesity and its associated metabolic comorbidities are a rising global health and social issue, with novel therapeutic approaches urgently needed. Adipose tissue plays a key role in the regulation of energy balance and adipose tissue-derived mesenchymal stem cells (AT-MSCs) have gained great interest in cell therapy. Carnitine palmitoyltransferase 1A (CPT1A) is the gatekeeper enzyme for mitochondrial fatty acid oxidation. Here, we aimed to generate adipocytes expressing a constitutively active CPT1A form (CPT1AM) that can improve the obese phenotype in mice after their implantation. AT-MSCs were differentiated into mature adipocytes, subjected to lentivirus-mediated expression of CPT1AM or the GFP control, and subcutaneously implanted into mice fed a high-fat diet (HFD). CPT1AM-implanted mice showed lower body weight, hepatic steatosis and serum insulin and cholesterol levels alongside improved glucose tolerance. HFD-induced increases in adipose tissue hypertrophy, fibrosis, inflammation, endoplasmic reticulum stress and apoptosis were reduced in CPT1AM-implanted mice. In addition, the expression of mitochondrial respiratory chain complexes was enhanced in the adipose tissue of CPT1AM-implanted mice. Our results demonstrate that implantation of CPT1AM-expressing AT-MSC-derived adipocytes into HFD-fed mice improves the obese metabolic phenotype, supporting the future clinical use of this ex vivo gene therapy approach., This study was supported by the Spanish Ministry of Science and Innovation (MCIN/AEI) (SAF2017-83813-C3-1-R and PID2020-114953RB-C21 to LH and DS and PID2019-108792GB-I00 supported by MCIN/AEI/10.13039/501100011033 and PDC2021-121051-I00 to AC, co-funded by the European Regional Development Fund [ERDF]), the Biomedical Research Centre in Pathophysiology of Obesity and Nutrition (CIBEROBN) (Grant CB06/03/0001 to LH), the Merck Health Foundation (to LH), the Government of Catalonia (2017SGR278 to DS and 2021SGR00367 to LH), the ERC-2020-PoC to AC, the Marató de TV3 Foundation (201627–30 to DS and 202012–32 to AC) and FIS PI21/01523 (to VLl-C), from Fundación BBVA Ayudas a equipos de investigación 2019 (“Translational Molecular Imaging for Detection of Cholesterol Entrapment in the Vasculature with 68Ga-labeled LRP1-derived Peptides” to VLl-C). VLl-C and JCE-G are part of CIBER Enfermedades Cardiovasculares (CIBERCV; CB16/11/00276) and CIBERDEM (CB07/08/0016), respectively, run by the Instituto de Salud Carlos III. MS-V is a recipient of the Ajut de Personal Investigador Predoctoral en Formació (APIF) doctoral fellowship from the University of Barcelona. AC is a recipient of an ICREA “Academia” Award (Generalitat de Catalunya).‬ AB-A is a fellow granted by the Program (FI19/00205) Contratos predoctorales de formación de investigación en salud_from the Instituto de Salud Carlos III (ISCIII) and co-financed with ERDFs. The authors thank Senda Jiménez-Delgado‬ for helping with the molecular work.‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk

  • Valdecantos, M. P.
  • Ruiz, Laura
  • Folgueira, Cintia
  • Rada, Patricia
  • Gómez-Santos, Beatriz
  • Solas, Maite
  • Hitos, Ana B.
  • Field, Joss
  • Francisco, Vera
  • Escalona-Garrido, Carmen
  • Zagmutt, Sebastián
  • Calderón‐Domínguez, María
  • Mera, Paula
  • García Martínez, Irma
  • Maymó-Masip, Elsa
  • Grajales, Diana
  • Alén, Rosa
  • Mora, Alfonso
  • Sáinz, Neira
  • Vides-Urrestarazu, Irene
  • Vilarrasa, Núria
  • Arbones-Mainar, José M
  • Zaragoza, Carlos
  • Moreno-Aliaga, María J.
  • Aspichueta, Patricia
  • Fernández-Veledo, Sonia
  • Vendrell, Joan
  • Serra, Dolors
  • Herrero, Laura
  • Schreiber, Renate
  • Zechner, Rudolf
  • Sabio, Guadalupe
  • Hornigold, David
  • Rondinone, Cristina M.
  • Jermutus, Lutz
  • Grimsby, J.
  • Valverde, Ángela M.
Bariatric surgery is effective for the treatment and remission of obesity and type 2 diabetes, but pharmacological approaches which exert similar metabolic adaptations are needed to avoid post-surgical complications. Here we show how G49, an oxyntomodulin (OXM) analog and dual glucagon/glucagon-like peptide-1 receptor (GCGR/GLP-1R) agonist, triggers an inter-organ crosstalk between adipose tissue, pancreas, and liver which is initiated by a rapid release of free fatty acids (FFAs) by white adipose tissue (WAT) in a GCGR-dependent manner. This interactome leads to elevations in adiponectin and fibroblast growth factor 21 (FGF21), causing WAT beiging, brown adipose tissue (BAT) activation, increased energy expenditure (EE) and weight loss. Elevation of OXM, under basal and postprandial conditions, and similar metabolic adaptations after G49 treatment were found in plasma from patients with obesity early after metabolic bariatric surgery. These results identify G49 as a potential pharmacological alternative sharing with bariatric surgery hormonal and metabolic pathways., This work was funded by grants RTI2018-094052-B-100 funded by MICIU/AEI/10.13039/501100011033/ and by ERDF “A way of making Europe” and PID-2021-122766OB-100 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU, P2022/BMD-7227 (Comunidad de Madrid, Spain) and CIBERDdem (ISCIII) to A.M.V. and M.P.V., grants PID2020-114953RB-C21 funded by MICIU/AEI/10.13039/501100011033 to L.H. and D.S., CB06/03/0001 (CIBERobn, ISCIII, Spain) and 2021SGR00367 (Government of Catalonia) to L.H., grants PID2019-106982RB-I00 funded by MICIU/AEI/10.13039/501100011033 and CB12/03/30002 (CIBERobn, ISCIII, Spain) to M.J.M.-A., grants AECC PROYE19047SABI, PMP21/00057 Infraestructura de Medicina de Precisión asociada a la Ciencia y Tecnología IMPACT-2021, Instituto de Salud Carlos III, PDC2021-121147-I00 funded by MICIU/AEI/10.13039/501100011033 and the “European Union NextGeneration/PRTR” and PID2022-138525OB-I00 funded by MICIU/AEI/10.13039/501100011033 and ERDF/EU to G.S., grant PID2021-122480OB-100 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU, and 2021 SGR 01409 (Generalitat de Catalunya) to S.F.V., grant PID2021-128737NB-I00 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU to M.S., grants PI20/00338, PI23/01133 (ISCIII, Spain), and 2021 SGR 00829 (Government of Catalunya) to J.V., grants PI17/01556 and PI22/01773 (ISCIII, Spain) to N.V., grants IT1476-22 funded by Basque Government, Department of Education and PID2021-124425OB-100 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU to P.A. and F7302 SFB‐Lipid‐Hydrolysis from the Austrian Science Fund FWF and 12CVD04 from the Leducq Foundation both to R.Z. C.F. was funded by EASO/Novo Nordisk New Investigator Award in Basic Sciences 2023, EFSD/Novo Nordisk Rising Star 2024 and IBSA Foundation Fellowship Endocrinology 2023. V.F. was supported by “Albert Renold Travel Fellowship” grant from EFSD., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

CPT1A in AgRP neurons is required for sex-dependent regulation of feeding and thirst

  • Zagmutt, Sebastián
  • Martin, Beatriz
  • Esteve-Codina, Anna
  • Serra, Dolors
Background: Fatty acid metabolism in the hypothalamus has an important role in food intake, but its specific role in AgRP neurons is poorly understood. Here, we examined whether carnitinea palmitoyltransferase 1A (CPT1A), a key enzyme in mitochondrial fatty acid oxidation, affects energy balance. Methods: To obtain Cpt1aKO mice and their control littermates, Cpt1a(flox/flox) mice were crossed with tamoxifen-inducible AgRPCreERT2 mice. Food intake and body weight were analyzed weekly in both males and females. At 12 weeks of age, metabolic flexibility was determined by ghrelin-induced food intake and fasting-refeeding satiety tests. Energy expenditure was analyzed by calorimetric system and thermogenic activity of brown adipose tissue. To study fluid balance the analysis of urine and water intake volumes; osmolality of urine and plasma; as well as serum levels of angiotensin and components of RAAS (renin-angiotensin-aldosterone system) were measured. At the central level, changes in AgRP neurons were determined by: (1) analyzing specific AgRP gene expression in RiboTag-Cpt1aKO mice obtained by crossing Cpt1aKO mice with RiboTag mice; (2) measuring presynaptic terminal formation in the AgRP neurons with the injection of the AAV1-EF1a-DIO-synaptophysin-GFP in the arcuate nucleus of the hypothalamus; (3) analyzing AgRP neuronal viability and spine formations by the injection AAV9-EF1a-DIO-mCherry in the arcuate nucleus of the hypothalamus; (4) analyzing in situ the specific AgRP mitochondria in the ZsGreen-Cpt1aKO obtained by breeding ZsGreen mice with Cpt1aKO mice. Two-way ANOVA analyses were performed to determine the contributions of the effect of lack of CPT1A in AgRP neurons in the sex. Results: Changes in food intake were just seen in male Cpt1aKO mice while only female Cpt1aKO mice increased energy expenditure. The lack of Cpt1a in the AgRP neurons enhanced brown adipose tissue activity, mainly in females, and induced a substantial reduction in fat deposits and body weight. Strikingly, both male and female Cpt1aKO mice showed polydipsia and polyuria, with more reduced serum vasopressin levels in females and without osmolality alterations, indicating a direct involvement of Cpt1a in AgRP neurons in fluid balance. AgRP neurons from Cpt1aKO mice showed a sex-dependent gene expression pattern, reduced mitochondria and decreased presynaptic innervation to the paraventricular nucleus, without neuronal viability alterations. Conclusions: Our results highlight that fatty acid metabolism and CPT1A in AgRP neurons show marked sex differences and play a relevant role in the neuronal processes necessary for the maintenance of whole-body fluid and energy balance., This study was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) (SAF2017-83813-C3-1-R to DS and LH, cofunded by the European Regional Development Fund [ERDF] and PID2020-114953RB-C21 to LH and DS, RTI2018-094727-B-100 to JMG; SAF2017-88108-R to AQ; AEI (PID2020-114977RB-I00) to AQ, ERC-2014-StG-638106 to AQ, MICINN RYC2019-028501-I to ES; MICIU RTI2018-101838-J-I00 to ES; a doctoral fellowship to SZ, and a Juan de la Cierva-Incorporación Research Fellowship [IJCI-2016-28313] to PM and DS), the Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) (CB06/03/0001 to DS and LH), the Government of Catalonia (2014SGR465 to DS), and La Marató de TV3 (201627-30 to DS). AO is supported by a Miguel Servet contract (CP19/00083) from Instituto de Salud Carlos III co-financed by European Regional Development Fund [ERDF]. AE is funded by ISCIII /MINECO (PT17/0009/0019) and co-funded by FEDER.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

To be or not to be a fat burner, that is the question for cpt1c in cancer cells

  • Fadó Andrés, Rut
  • Zagmutt, Sebastián
  • Herrero, Laura
  • Muley, Helena
  • Rodriguez-Rodriguez, Rosalia
  • Bi, Huichang
  • Serra, Dolors
  • Casals, Nuria
This study was supported by the Spanish Ministry of Science and Innovation (MCIN) (PID2020-114953RB-C21 to LH and DS, and PID2020-114953RB-C22 to NC and RR cofunded by the European Regional Development Fund), the Biomedical Research Center in Pathophysiology of Obesity and Nutrition (CIBEROBN) (Grant CB06/03/0001 to LH), the Merck Health Foundation (to LH), the Government of Catalonia (2017SGR278 to DS), and the Marató de TV3 Foundation (201627-30 to DS and NC). Figures were created with BioRender.com., There is an urgent need to identify reliable genetic biomarkers for accurate diagnosis, prognosis, and treatment of different tumor types. Described as a prognostic marker for many tumors is the neuronal protein carnitine palmitoyltransferase 1 C (CPT1C). Several studies report that CPT1C is involved in cancer cell adaptation to nutrient depletion and hypoxia. However, the molecular role played by CPT1C in cancer cells is controversial. Most published studies assume that, like canonical CPT1 isoforms, CPT1C is a mediator of fatty acid transport to mitochondria for beta-oxidation, despite the fact that CPT1C has inefficient catalytic activity and is located in the endoplasmic reticulum. In this review, we collate existing evidence on CPT1C in neurons, showing that CPT1C is a sensor of nutrients that interacts with and regulates other proteins involved in lipid metabolism and transport, lysosome motility, and the secretory pathway. We argue, therefore, that CPT1C expression in cancer cells is not a direct regulator of fat burn, but rather is a regulator of lipid metabolic reprograming and cell adaptation to environmental stressors. We also review the clinical relevance of CPT1C as a prognostic indicator and its contribution to tumor growth, cancer invasiveness, and cell senescence. This new and integrated vision of CPT1C function can help better understand the metabolic plasticity of cancer cells and improve the design of therapeutic strategies., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice

  • Soler Vázquez, M. Carmen
  • Romero, María del Mar
  • Todorcevic, Marijana
  • Delgado, Katia
  • Calatayud, Carles
  • Benítez Amaro, Aleyda
  • La Chica Lhoëst, María Teresa
  • Mera, Paula
  • Zagmutt, Sebastián
  • Bastías Pérez, Marianela Pía
  • Ibeas, Kevin
  • Casals, Núria
  • Escola-Gil, Joan Carles
  • Llorente Cortés, Vicenta
  • Consiglio, Antonella
  • Serra, Dolors
  • Herrero, Laura
This study was supported by the Spanish Ministry of Science and Innovation (MCIN/AEI) (SAF2017-83813-C3-1-R and PID2020-114953RB-C21 to LH and DS and PID2019-108792GB-I00 supported by MCIN/AEI/10.13039/501100011033 and PDC2021-121051-I00 to AC, co-funded by the European Regional Development Fund [ERDF]), the Biomedical Research Centre in Pathophysiology of Obesity and Nutrition (CIBEROBN) (Grant CB06/03/0001 to LH), the Merck Health Foundation (to LH), the Government of Catalonia (2017SGR278 to DS and 2021SGR00367 to LH), the ERC-2020-PoC to AC, the Marato ´ de TV3 Foundation (201627–30 to DS and 202012–32 to AC) and FIS PI21/01523 (to VLl-C), from Fundacion ´ BBVA Ayudas a equipos de inves tigacion ´ 2019 (“Translational Molecular Imaging for Detection of Cholesterol Entrapment in the Vasculature with 68Ga-labeled LRP1-derived Peptides” to VLl-C). VLl-C and JCE-G are part of CIBER Enfer medades Cardiovasculares (CIBERCV; CB16/11/00276) and CIBERDEM (CB07/08/0016), respectively, run by the Instituto de Salud Carlos III. MS-V is a recipient of the Ajut de Personal Investigador Predoctoral en Formació (APIF) doctoral fellowship from the University of Barcelona. AC is a recipient of an ICREA “Academia” Award (Generalitat de Catalunya). AB-A is a fellow granted by the Program (FI19/00205) Contratos predoctorales de formación de investigación en salud_from the Instituto de Salud Carlos III (ISCIII) and co-financed with ERDFs. The authors thank Senda Jim´enez-Delgado for helping with the molecular work., Obesity and its associated metabolic comorbidities are a rising global health and social issue, with novel therapeutic approaches urgently needed. Adipose tissue plays a key role in the regulation of energy balance and adipose tissue-derived mesenchymal stem cells (AT-MSCs) have gained great interest in cell therapy. Carnitine palmitoyltransferase 1A (CPT1A) is the gatekeeper enzyme for mitochondrial fatty acid oxidation. Here, we aimed to generate adipocytes expressing a constitutively active CPT1A form (CPT1AM) that can improve the obese phenotype in mice after their implantation. AT-MSCs were differentiated into mature adipocytes, subjected to lentivirus-mediated expression of CPT1AM or the GFP control, and subcutaneously implanted into mice fed a high-fat diet (HFD). CPT1AM-implanted mice showed lower body weight, hepatic steatosis and serum insulin and cholesterol levels alongside improved glucose tolerance. HFD-induced increases in adipose tissue hypertrophy, fibrosis, inflammation, endoplasmic reticulum stress and apoptosis were reduced in CPT1AM-implanted mice. In addition, the expression of mitochondrial respiratory chain complexes was enhanced in the adipose tissue of CPT1AM-implanted mice. Our results demonstrate that implantation of CPT1AM-expressing AT-MSC-derived adipocytes into HFD-fed mice improves the obese metabolic phenotype, supporting the future clinical use of this ex vivo gene therapy approach., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

CPT1A in AgRP neurons is required for sex-dependent regulation of feeding and thirst

  • Zagmutt, Sebastián
  • Mera, Paula
  • González-García, Ismael
  • Ibeas, Kevin
  • Romero, María del Mar
  • Obri, Arnaud
  • Martin, Beatriz
  • Esteve-Codina, Anna
  • Soler Vázquez, M. Carmen
  • Bastías Pérez, Marianela Pía
  • Cañes, Laia
  • Augé, Elisabeth
  • Pelegri, Carme
  • Vilaplana, Jordi
  • Ariza, Xavier
  • García, Jordi
  • Martinez González, José
  • Casals, Núria
  • López, Miguel
  • Palmiter, Richard
  • Sanz, Elisenda
  • Quintana, Albert
  • Herrero, Laura
  • Serra, Dolors
This study was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) (SAF2017-83813-C3-1-R to DS and LH, cofunded by the European Regional Development Fund [ERDF] and PID2020-114953RB-C21 to LH and DS, RTI2018-094727-B-100 to JMG; SAF2017-88108-R to AQ; AEI (PID2020-114977RB-I00) to AQ, ERC-2014-StG-638106 to AQ, MICINN RYC2019028501-I to ES; MICIU RTI2018-101838-J-I00 to ES; a doctoral fellowship to SZ, and a Juan de la Cierva-Incorporación Research Fellowship [IJCI-2016-28313] to PM and DS), the Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) (CB06/03/0001 to DS and LH), the Government of Catalonia (2014SGR465 to DS), and La Marató de TV3 (201627-30 to DS). AO is supported by a Miguel Servet contract (CP19/00083) from Instituto de Salud Carlos III co-fnanced by European Regional Development Fund [ERDF]. AE is funded by ISCIII /MINECO (PT17/0009/0019) and co-funded by FEDER., Background: Fatty acid metabolism in the hypothalamus has an important role in food intake, but its specific role in AgRP neurons is poorly understood. Here, we examined whether carnitinea palmitoyltransferase 1A (CPT1A), a key enzyme in mitochondrial fatty acid oxidation, affects energy balance. Methods: To obtain Cpt1aKO mice and their control littermates, Cpt1a(flox/flox) mice were crossed with tamoxifen-inducible AgRPCreERT2 mice. Food intake and body weight were analyzed weekly in both males and females. At 12 weeks of age, metabolic flexibility was determined by ghrelin-induced food intake and fasting–refeeding satiety tests. Energy expenditure was analyzed by calorimetric system and thermogenic activity of brown adipose tissue. To study fluid balance the analysis of urine and water intake volumes; osmolality of urine and plasma; as well as serum levels of angiotensin and components of RAAS (renin–angiotensin–aldosterone system) were measured. At the central level, changes in AgRP neurons were determined by: (1) analyzing specific AgRP gene expression in RiboTag–Cpt1aKO mice obtained by crossing Cpt1aKO mice with RiboTag mice; (2) measuring presynaptic terminal formation in the AgRP neurons with the injection of the AAV1-EF1a-DIO-synaptophysin-GFP in the arcuate nucleus of the hypothalamus; (3) analyzing AgRP neuronal viability and spine formations by the injection AAV9-EF1a-DIO-mCherry in the arcuate nucleus of the hypothalamus; (4) analyzing in situ the specific AgRP mitochondria in the ZsGreen-Cpt1aKO obtained by breeding ZsGreen mice with Cpt1aKO mice. Two-way ANOVA analyses were performed to determine the contributions of the effect of lack of CPT1A in AgRP neurons in the sex. Results: Changes in food intake were just seen in male Cpt1aKO mice while only female Cpt1aKO mice increased energy expenditure. The lack of Cpt1a in the AgRP neurons enhanced brown adipose tissue activity, mainly in females, and induced a substantial reduction in fat deposits and body weight. Strikingly, both male and female Cpt1aKO mice showed polydipsia and polyuria, with more reduced serum vasopressin levels in females and without osmolality alterations, indicating a direct involvement of Cpt1a in AgRP neurons in fluid balance. AgRP neurons from Cpt1aKO mice showed a sex-dependent gene expression pattern, reduced mitochondria and decreased presynaptic innervation to the paraventricular nucleus, without neuronal viability alterations. Conclusions: Our results highlight that fatty acid metabolism and CPT1A in AgRP neurons show marked sex differences and play a relevant role in the neuronal processes necessary for the maintenance of whole-body fluid and energy balance., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Nanomedicine targeting brain lipid metabolism as a feasible approach for controlling the energy balance

  • García-Chica, Jesús
  • Paraiso, West Kristian
  • Zagmutt, Sebastián
  • Fosch, Anna
  • Reguera, Ana Cristina
  • Alzina, Sara
  • Sánchez-García, Laura
  • Fukushima, Shigeto
  • Toh, Kazuko
  • Casals, Núria
  • Serra, Dolors
  • Herrero, Laura
  • Garcia Gomez, Jordi
  • Kataoka, Kazunori
  • Ariza, Xavier
  • Quader, Sabina
  • Rodriguez-Rodriguez, Rosalia
This project was financially supported by the Joint Bilateral Project Japan-Spain (PCI2018-092997 to R. R.-R.)/Agencia Estatal de Investigación (AEI) and (20jm0210059h0003 to S.Q.)/Agency for Medical Research and Development (AMED), the Japan Society for Promotion of Science (JSPS) Bilateral Joint Research Projects (JPJSBP120209938 to S. Q.), and the Center of Innovation (COI) Program (JPMJCE1305) from Japan Science and Technology Agency (JST). This study was also supported by the Ministerio de Ciencia e Innovación (MCIN/AEI/10.13039/501100011033) (PID2020-114953RB-C22 to N. C. and R. R.-R.; PID2020-114953RB-C21 to L. H. and D. S.) co-funded by the European Regional Development Fund [ERDF], the Biomedical Research Centre in Pathophysiology of Obesity and Nutrition (CIBEROBN) (grant CB06/03/0001 to L. H.), and the Merck Health Foundation (to L. H.)., Targeting brain lipid metabolism is a promising strategy to regulate the energy balance and fight metabolic diseases such as obesity. The development of stable platforms for selective delivery of drugs, particularly to the hypothalamus, is a challenge but a possible solution for these metabolic diseases. Attenuating fatty acid oxidation in the hypothalamus via CPT1A inhibition leads to satiety, but this target is difficult to reach in vivo with the current drugs. We propose using an advanced crosslinked polymeric micelle-type nanomedicine that can stably load the CPT1A inhibitor C75-CoA for in vivo control of the energy balance. Central administration of the nanomedicine induced a rapid attenuation of food intake and body weight in mice via regulation of appetite-related neuropeptides and neuronal activation of specific hypothalamic regions driving changes in the liver and adipose tissue. This nanomedicine targeting brain lipid metabolism was successful in the modulation of food intake and peripheral metabolism in mice., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

To be or not to be a fat burner, that is the question for cpt1c in cancer cells

  • Fadó, Rut|||0000-0002-3293-2342
  • Zagmutt, Sebastian|||0000-0001-6050-4452
  • Herrero, Laura|||0000-0003-4244-4673
  • Muley, Helena|||0000-0003-0979-4815
  • Rodríguez-Rodríguez, Rosalía
  • Bi, Huichang
  • Serra, Dolors|||0000-0002-4936-4206
  • Casals, Nuria|||0000-0002-6719-4300
There is an urgent need to identify reliable genetic biomarkers for accurate diagnosis, prognosis, and treatment of different tumor types. Described as a prognostic marker for many tumors is the neuronal protein carnitine palmitoyltransferase 1 C (CPT1C). Several studies report that CPT1C is involved in cancer cell adaptation to nutrient depletion and hypoxia. However, the molecular role played by CPT1C in cancer cells is controversial. Most published studies assume that, like canonical CPT1 isoforms, CPT1C is a mediator of fatty acid transport to mitochondria for beta-oxidation, despite the fact that CPT1C has inefficient catalytic activity and is located in the endoplasmic reticulum. In this review, we collate existing evidence on CPT1C in neurons, showing that CPT1C is a sensor of nutrients that interacts with and regulates other proteins involved in lipid metabolism and transport, lysosome motility, and the secretory pathway. We argue, therefore, that CPT1C expression in cancer cells is not a direct regulator of fat burn, but rather is a regulator of lipid metabolic reprograming and cell adaptation to environmental stressors. We also review the clinical relevance of CPT1C as a prognostic indicator and its contribution to tumor growth, cancer invasiveness, and cell senescence. This new and integrated vision of CPT1C function can help better understand the metabolic plasticity of cancer cells and improve the design of therapeutic strategies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

CPT1A in AgRP neurons is required for sex-dependent regulation of feeding and thirst

  • Zagmutt, Sebastian|||0000-0001-6050-4452
  • Mera, Paula|||0000-0001-8941-4637
  • González-García, Ismael
  • Ibeas, Kevin
  • Romero, María del Mar|||0000-0001-6274-5743
  • Obri, Arnaud
  • Martin, Beatriz
  • Esteve-Codina, Anna|||0000-0003-0361-2873
  • Soler Vázquez, M. Carmen|||0000-0003-1430-5617
  • Bastías Pérez, Marianela|||0000-0003-0098-8090
  • Cañes Esteve, Laia|||0000-0002-9579-1321
  • Augé, Elisabeth
  • Pelegri, Carme
  • Vilaplana, Jordi|||0000-0002-8188-4914
  • Ariza, Xavier
  • García, Jordi
  • Martinez-González, José
  • Casals, Nuria|||0000-0002-6719-4300
  • López, Miguel
  • Palmiter, Richard
  • Sanz Iglesias, Elisenda|||0000-0002-7932-8556
  • Quintana Romero, Albert|||0000-0003-1674-7160
  • Herrero, Laura|||0000-0003-4244-4673
  • Serra, Dolors|||0000-0002-4936-4206
Fatty acid metabolism in the hypothalamus has an important role in food intake, but its specific role in AgRP neurons is poorly understood. Here, we examined whether carnitinea palmitoyltransferase 1A (CPT1A), a key enzyme in mitochondrial fatty acid oxidation, affects energy balance. To obtain Cpt1a KO mice and their control littermates, Cpt1a (flox/flox) mice were crossed with tamoxifen-inducible AgRP CreERT2 mice. Food intake and body weight were analyzed weekly in both males and females. At 12 weeks of age, metabolic flexibility was determined by ghrelin-induced food intake and fasting-refeeding satiety tests. Energy expenditure was analyzed by calorimetric system and thermogenic activity of brown adipose tissue. To study fluid balance the analysis of urine and water intake volumes; osmolality of urine and plasma; as well as serum levels of angiotensin and components of RAAS (renin-angiotensin-aldosterone system) were measured. At the central level, changes in AgRP neurons were determined by: (1) analyzing specific AgRP gene expression in RiboTag- Cpt1a KO mice obtained by crossing Cpt1a KO mice with RiboTag mice; (2) measuring presynaptic terminal formation in the AgRP neurons with the injection of the AAV1 -EF1a-DIO-synaptophysin-GFP in the arcuate nucleus of the hypothalamus; (3) analyzing AgRP neuronal viability and spine formations by the injection AAV9 -EF1a-DIO-mCherry in the arcuate nucleus of the hypothalamus; (4) analyzing in situ the specific AgRP mitochondria in the ZsGreen- Cpt1a KO obtained by breeding ZsGreen mice with Cpt1a KO mice. Two-way ANOVA analyses were performed to determine the contributions of the effect of lack of CPT1A in AgRP neurons in the sex. Changes in food intake were just seen in male Cpt1a KO mice while only female Cpt1a KO mice increased energy expenditure. The lack of Cpt1a in the AgRP neurons enhanced brown adipose tissue activity, mainly in females, and induced a substantial reduction in fat deposits and body weight. Strikingly, both male and female Cpt1a KO mice showed polydipsia and polyuria, with more reduced serum vasopressin levels in females and without osmolality alterations, indicating a direct involvement of Cpt1a in AgRP neurons in fluid balance. AgRP neurons from Cpt1a KO mice showed a sex-dependent gene expression pattern, reduced mitochondria and decreased presynaptic innervation to the paraventricular nucleus, without neuronal viability alterations. Our results highlight that fatty acid metabolism and CPT1A in AgRP neurons show marked sex differences and play a relevant role in the neuronal processes necessary for the maintenance of whole-body fluid and energy balance. The online version contains supplementary material available at 10.1186/s13293-023-00498-8. The online version contains supplementary material available at 10.1186/s13293-023-00498-8.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice

  • Soler Vázquez, M. Carmen|||0000-0003-1430-5617
  • Romero, María del Mar|||0000-0001-6274-5743
  • Todorcevic, Marijana
  • Delgado, Katia
  • Calatayud, Carles|||0000-0003-0032-4198
  • Benitez Amaro, Aleyda|||0000-0002-1106-3125
  • La Chica Lhoëst, María Teresa|||0000-0002-9070-5973
  • Mera, Paula|||0000-0001-8941-4637
  • Zagmutt, Sebastian|||0000-0001-6050-4452
  • Bastías Pérez, Marianela|||0000-0003-0098-8090
  • Ibeas, Kevin
  • Casals, Nuria|||0000-0002-6719-4300
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
  • Consiglio, Antonella
  • Serra, Dolors|||0000-0002-4936-4206
  • Herrero, Laura|||0000-0003-4244-4673
Obesity and its associated metabolic comorbidities are a rising global health and social issue, with novel therapeutic approaches urgently needed. Adipose tissue plays a key role in the regulation of energy balance and adipose tissue-derived mesenchymal stem cells (AT-MSCs) have gained great interest in cell therapy. Carnitine palmitoyltransferase 1A (CPT1A) is the gatekeeper enzyme for mitochondrial fatty acid oxidation. Here, we aimed to generate adipocytes expressing a constitutively active CPT1A form (CPT1AM) that can improve the obese phenotype in mice after their implantation. AT-MSCs were differentiated into mature adipocytes, subjected to lentivirus-mediated expression of CPT1AM or the GFP control, and subcutaneously implanted into mice fed a high-fat diet (HFD). CPT1AM-implanted mice showed lower body weight, hepatic steatosis and serum insulin and cholesterol levels alongside improved glucose tolerance. HFD-induced increases in adipose tissue hypertrophy, fibrosis, inflammation, endoplasmic reticulum stress and apoptosis were reduced in CPT1AM-implanted mice. In addition, the expression of mitochondrial respiratory chain complexes was enhanced in the adipose tissue of CPT1AM-implanted mice. Our results demonstrate that implantation of CPT1AM-expressing AT-MSC-derived adipocytes into HFD-fed mice improves the obese metabolic phenotype, supporting the future clinical use of this ex vivo gene therapy approach.